We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australian Regulators Fine Drugmakers for Misleading Claims, Breaching Code of Conduct
Australian Regulators Fine Drugmakers for Misleading Claims, Breaching Code of Conduct
November 17, 2010
Medicines Australia has fined several drugmakers for misleading advertising and/or breaching its code of conduct, including a $200,000 fine to Roche for making misleading claims about its anemia drug Mircera.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor